Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Stake as of Sep 30, 2026 · Filed Nov 12, 2026
The holder reported owning less than 5%, which ends its duty to keep reporting this stake.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
Undefined
Compared with the manager's prior 13F
—
NaN
For the same quarter
Insider buying
Traded Nov 11 · filed 2 days later
The CFO of Aldeyra Therapeutics paid $6.5K out of pocket for Aldeyra Therapeutics shares. 1 other person at Aldeyra Therapeutics bought some too, in the same month. It was the first purchase in 8 months.
Insider buying
Traded Nov 11 · filed 2 days later
An Aldeyra Therapeutics director paid $129K out of pocket for Aldeyra Therapeutics shares. 1 other person at Aldeyra Therapeutics bought some too, in the same month. It was the first purchase in 8 months.
Fund moves
A Schedule 13G is filed by holders above 5% who say they will not try to influence the company. Index funds and large asset managers file most of them.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
